NewsRx

Search our medical news database

Vectors (Alternative)

Cationic Facial Amphiphiles - Nonviral Transfecting Agents

Published in Gene Therapy Weekly, March 11th, 1996

The transfecting capabilities of cationic facial amphiphiles outperform commercially available Lipofectin.

Cationic lipids have shown the most promise as nonviral DNA delivery systems based on a combination of efficacy, stability, and low toxicity. Lipofectin is a 1:1 mixture of a cationic lipid, DOTMA and a fusogenic lipid, DOPE. The mechanism by which these cationic lipid formulations promote DNA uptake is not completely understood. It has been determined that the cationic component is necessary in any effective gene delivery agent, but the potential exists for something other than a fusogenic lipid to successfully partner with the cationic lipid.

...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook